Baltimore, MD, Sept. 8, 2015 -- Geroprotectors are interventions that aim to prevent, slow, or reverse the processes of aging in model organisms or humans such that the lifespan, and especially the healthy lifespan, can be extended. They can target any one of many pathways and gene networks involved in aging. However, because this is new territory for medical science geroprotectors and their effects remain largely uncatalogued.

Insilico Medicine, a company specializing in drug repurposing in cancer and bioinformatics of aging based at the Emerging Technology Centers at the Johns Hopkins University contributed to the development of Geroprotectors.org. This web-based knowledge management system is billed as a structured and curated database of therapeutic interventions in aging and age related diseases.

• Назад
• Вперед